WMT

113.17

-1.62%↓

PG

139.82

+0.14%↑

KO

70.23

+0.21%↑

PM

149.34

-0.68%↓

PEP

149.67

+3.48%↑

WMT

113.17

-1.62%↓

PG

139.82

+0.14%↑

KO

70.23

+0.21%↑

PM

149.34

-0.68%↓

PEP

149.67

+3.48%↑

WMT

113.17

-1.62%↓

PG

139.82

+0.14%↑

KO

70.23

+0.21%↑

PM

149.34

-0.68%↓

PEP

149.67

+3.48%↑

WMT

113.17

-1.62%↓

PG

139.82

+0.14%↑

KO

70.23

+0.21%↑

PM

149.34

-0.68%↓

PEP

149.67

+3.48%↑

WMT

113.17

-1.62%↓

PG

139.82

+0.14%↑

KO

70.23

+0.21%↑

PM

149.34

-0.68%↓

PEP

149.67

+3.48%↑

Search

USANA Health Sciences Inc

Закрыт

20.73 3.34

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

19.64

Макс.

21.04

Ключевые показатели

By Trading Economics

Доход

-17M

-6.7M

Продажи

-22M

214M

P/E

Средняя по отрасли

21.567

28.852

Прибыль на акцию

-0.15

Рентабельность продаж

-3.118

Сотрудники

1,700

EBITDA

-17M

11M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+94.42% upside

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-27M

355M

Предыдущая цена открытия

17.39

Предыдущая цена закрытия

20.73

Техническая оценка

By Trading Central

Уверенность

Weak Bullish Evidence

USANA Health Sciences Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

10 дек. 2025 г., 22:02 UTC

Отчет

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

10 дек. 2025 г., 21:46 UTC

Отчет

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

10 дек. 2025 г., 23:52 UTC

Приобретения, слияния, поглощения

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

10 дек. 2025 г., 23:43 UTC

Обсуждения рынка

Nikkei May Rise After Fed Rate Cut -- Market Talk

10 дек. 2025 г., 23:36 UTC

Обсуждения рынка

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

10 дек. 2025 г., 23:20 UTC

Отчет

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

10 дек. 2025 г., 23:15 UTC

Отчет

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

10 дек. 2025 г., 22:59 UTC

Обсуждения рынка
Отчет
Приобретения, слияния, поглощения

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

10 дек. 2025 г., 22:45 UTC

Обсуждения рынка

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

10 дек. 2025 г., 22:40 UTC

Отчет

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 дек. 2025 г., 22:06 UTC

Приобретения, слияния, поглощения

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 дек. 2025 г., 22:06 UTC

Отчет

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 дек. 2025 г., 22:02 UTC

Отчет

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 дек. 2025 г., 22:00 UTC

Отчет

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

10 дек. 2025 г., 21:53 UTC

Отчет

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 дек. 2025 г., 21:50 UTC

Приобретения, слияния, поглощения

Investors Bet That a Higher Bid for Warner Is Coming -- Update

10 дек. 2025 г., 21:50 UTC

Обсуждения рынка
Отчет
Приобретения, слияния, поглощения

Financial Services Roundup: Market Talk

10 дек. 2025 г., 21:50 UTC

Обсуждения рынка

Health Care Roundup: Market Talk

10 дек. 2025 г., 21:50 UTC

Обсуждения рынка

Auto & Transport Roundup: Market Talk

10 дек. 2025 г., 21:45 UTC

Приобретения, слияния, поглощения

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 дек. 2025 г., 21:33 UTC

Отчет

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

10 дек. 2025 г., 21:32 UTC

Отчет

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 дек. 2025 г., 21:28 UTC

Приобретения, слияния, поглощения

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

10 дек. 2025 г., 21:25 UTC

Отчет

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 дек. 2025 г., 21:18 UTC

Приобретения, слияния, поглощения

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

10 дек. 2025 г., 21:16 UTC

Отчет

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

10 дек. 2025 г., 21:15 UTC

Приобретения, слияния, поглощения

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

10 дек. 2025 г., 21:15 UTC

Отчет

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

10 дек. 2025 г., 21:14 UTC

Отчет

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

10 дек. 2025 г., 21:14 UTC

Отчет

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

Сравнение c конкурентами

Изменение цены

USANA Health Sciences Inc Прогноз

Целевая цена

By TipRanks

94.42% рост

Прогноз на 12 месяцев

Средняя 39 USD  94.42%

Максимум 39 USD

Минимум 39 USD

Основано на мнении 1 аналитиков Wall Street, спрогнозировавших целевые цены для USANA Health Sciences Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

1 ratings

0

Покупка

1

Удержание

0

Продажа

Техническая оценка

By Trading Central

28.405 / 29.84Поддержка и Сопротивление

Краткосрочная

Weak Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

No Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat